Animal biotechnology involves the application of scientific tools and techniques to bring changes at the molecular level to improve animal health, reproduction, and nutrition. It helps in developing animal breeds that are more resistant to diseases and have higher meat and milk production capabilities. Some key applications of animal biotechnology include transgenic animal, animal genetics, cloning, DNA sexing, embryonic stem cell, molecular diagnostics, and bioinformatics.

The global animal biotechnology market is estimated to be valued at US$ 27.39 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the key drivers fueling the growth of the global animal biotechnology market size is the rising demand for animal protein globally. According to FAO, the demand for meat is projected to increase by over 70% by 2050 due to the growing population and rising purchasing power in developing nations. This is prompting livestock farmers to adopt advanced biotechnological tools and techniques to boost animal productivity and meat production. Animal biotechnology aids in developing high-yielding breeds through genetic modification, transgenic techniques, and cloning.

The growing demand for animal protein is leading to the increased adoption of animal biotechnology solutions among farmers. Tools such as DNA tests enable identifying superior breeds at an early stage, while reproductive and genetic engineering techniques help in enhancing livestock growth efficiency. This is expected to propel the animal biotechnology market growth over the forecast period.

SWOT Analysis
Strength: The global animal biotechnology market is growing rapidly due to increasing demand for food products. Rising consumption of meat, eggs and dairy has increased demand for biotechnological methods to enhance animal growth and quality of produce. Advancements in genomic sequencing and gene editing technologies also provide opportunities to study and breed disease resistant animals.

Weakness: High costs associated with R&D and clinical trials for new animal biotechnology products pose a challenge for market growth. Stringent regulations regarding testing of novel technologies on animals also delay product commercialization. Dependence on government funding and investor support further threatens consistent innovation.

Opportunity: Opportunities lie in developing cost-effective diagnostics, vaccines and therapeutics for zoonotic diseases through genetic engineering. Growing focus on protein alternatives to meat also opens markets for cultured meat and dairy. Developing countries with rising incomes present new customer segments for veterinary care products.

Threats: Ethical concerns around genetic modification and artificial breeding practices may negatively impact social acceptance. Competition from conventional breeding limits commercial viability of some technologies. Emergence of new animal pathogens poses risks despite progress in biosecurity measures. Trade barriers and differing regulations across regions also restrict market access.

Key Takeaways
The global animal biotechnology market is expected to witness high growth over the forecast period due to rising consumption of animal protein and demand for improved livestock productivity. The market size for animal biotechnology was valued at US$ 27.39 billion in 2024 and is projected to reach over US$ 50 billion by 2031, registering a CAGR of 8.9% .

Regional analysis: North America currently dominates the global animal biotechnology market due to advanced research infrastructure and adoption of novel technologies among veterinarians. However, Asia Pacific is expected to witness the fastest growth through 2031 on the back of rapid economic development, rising incomes, and increasing focus on high quality animal food production to meet domestic demand. Countries like China, India, and Japan are emerging as key markets for veterinary biologics, diagnostics and genetic engineering services.

Key players: Key players operating in the animal biotechnology market are Heska Corporation, Indian Immunologicals Ltd., HESTER BIOSCIENCES LIMITED, Zoetis Inc., Boehringer Ingelheim International GmbH, Biogénesis Bagó, Merck & Co., Inc., Virbac, Elanco, Cadila Pharma, Thermo Fisher Scientific Inc., Idexx Laboratories, Randox Laboratories Ltd., Gold Standard Diagnostics., Bionote USA Inc., Meiji Holdings Co., Ltd., Kemin Industries, Inc., and Pfizer Inc. The market remains fairly consolidated with top players focusing on product innovation and expansion into high growth emerging markets through collaborations.

Explore Our More Blogs Here: https://www.newsanalyticspro.com/global-animal-biotechnology-market-size-and-outlook/

 

Explore more trending article on this topic: https://masstamilan.tv/understanding-construction-aggregates/